Growing Market Presence Verista has demonstrated significant growth, evidenced by its recognition as one of the fastest-growing private companies in the US and an affiliation with Lightview Capital, indicating a strong market position and expansion potential within the life sciences consulting and technology services space.

Strategic Acquisitions The acquisition of Hawkins Point in early 2021 enhances Verista's service offerings and client base in the pharmaceutical and biotech sectors, providing new cross-selling opportunities with a focus on drug development and patient journey solutions.

Industry Expertise With a deep domain knowledge in life sciences and specialized leadership hires in regulatory compliance and business development, Verista is well-positioned to meet the complex needs of pharmaceutical companies seeking technology-driven solutions.

Technology Integration Utilizing advanced tech stacks including Google Cloud, Salesforce, and analytics tools like Qlik Sense, Verista offers scalable, data-driven solutions that can appeal to pharmaceutical clients aiming to optimize clinical, regulatory, and operational processes.

Revenue Opportunity With an estimated revenue range of 10 to 25 million dollars, Verista presents a targeted growth landscape for mid-tier pharmaceutical and biotech firms looking for specialized consulting and technology services to accelerate drug development and compliance efforts.